6-APB: Difference between revisions

Line 5:

| ''[[6-APB/Summary|Summary sheet: 6-APB]]''

|}

'''6-APB''' ('''3(6-(2-aminopropyl)benzofuran''') is a [[stimulant]] and [[Psychoactive class::entactogen]]ic research of the [[phenethylamine]] and [[Chemical class::Substituted amphetamines|amphetamine]] class. It is a close synthetic analogue to [[MDA]] and shares the broad characteristic of serotoonergic triple monoamine inhibitors and other [[entactogen]]ic or [[empathogen]]ic compounds.

'''6-APB''' ('''3(6-(2-aminopropyl)benzofuran''') is a [[stimulant]] and [[Psychoactive class::entactogen]]ic research of the [[Chemical class::phenethylamine]] and [[Chemical class::Substituted amphetamines|amphetamine]] class. It is a close synthetic analogue to [[MDA]] and shares the broad characteristic of serotoonergic triple monoamine inhibitors and other [[entactogen]]ic or [[empathogen]]ic compounds.

6-APB was first synthesized and studied in 1993 by the chemist David E. Nichols as a potential non-neurotoxic alternative to MDMA. It did not find common use until over a decade later briefly entered the rave and underground clubbing scene in the UK before its sale and import were banned. Because 6-APB and other substituted benzofurans have not been explicitly outlawed in some countries, they are often technically legal, contributing to their popularity.

@@ Line 5: / Line 5: @@
 | ''[[6-APB/Summary|Summary sheet: 6-APB]]''
 |}
-'''6-APB''' ('''3(6-(2-aminopropyl)benzofuran''') is a [[stimulant]] and [[Psychoactive class::entactogen]]ic research of the [[phenethylamine]] and [[Chemical class::Substituted amphetamines|amphetamine]] class. It is a close synthetic analogue to [[MDA]] and shares the broad characteristic of serotoonergic triple monoamine inhibitors and other [[entactogen]]ic or [[empathogen]]ic compounds.
+'''6-APB''' ('''3(6-(2-aminopropyl)benzofuran''') is a [[stimulant]] and [[Psychoactive class::entactogen]]ic research of the [[Chemical class::phenethylamine]] and [[Chemical class::Substituted amphetamines|amphetamine]] class. It is a close synthetic analogue to [[MDA]] and shares the broad characteristic of serotoonergic triple monoamine inhibitors and other [[entactogen]]ic or [[empathogen]]ic compounds.
 -APB was first synthesized and studied in 1993 by the chemist David E. Nichols as a potential non-neurotoxic alternative to MDMA. It did not find common use until over a decade later briefly entered the rave and underground clubbing scene in the UK before its sale and import were banned. Because 6-APB and other substituted benzofurans have not been explicitly outlawed in some countries, they are often technically legal, contributing to their popularity.